Correlation Between Basilea Pharmaceutica and Orior AG

Can any of the company-specific risk be diversified away by investing in both Basilea Pharmaceutica and Orior AG at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Basilea Pharmaceutica and Orior AG into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Basilea Pharmaceutica AG and Orior AG, you can compare the effects of market volatilities on Basilea Pharmaceutica and Orior AG and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Basilea Pharmaceutica with a short position of Orior AG. Check out your portfolio center. Please also check ongoing floating volatility patterns of Basilea Pharmaceutica and Orior AG.

Diversification Opportunities for Basilea Pharmaceutica and Orior AG

-0.7

Correlation Coefficient

Basilea Pharmaceutica  Orior AG

Excellent diversification

The 3 months correlation between Basilea and Orior is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Basilea Pharmaceutica AG and Orior AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orior AG and Basilea Pharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Basilea Pharmaceutica AG are associated (or correlated) with Orior AG. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orior AG has no effect on the direction of Basilea Pharmaceutica i.e., Basilea Pharmaceutica and Orior AG go up and down completely randomly.

Pair Corralation between Basilea Pharmaceutica and Orior AG

Assuming the 90 days trading horizon Basilea Pharmaceutica AG is expected to generate 0.47 times more return on investment than Orior AG. However, Basilea Pharmaceutica AG is 2.15 times less risky than Orior AG. It trades about 0.24 of its potential returns per unit of risk. Orior AG is currently generating about -0.08 per unit of risk. If you would invest  4,090  in Basilea Pharmaceutica AG on April 22, 2025 and sell it today you would earn a total of  1,290  from holding Basilea Pharmaceutica AG or generate 31.54% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Basilea Pharmaceutica AG  vs.  Orior AG

Basilea Pharmaceutica

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Basilea Pharmaceutica AG are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Basilea Pharmaceutica showed solid returns over the last few months and may actually be approaching a breakup point.

Orior AG

Risk-Adjusted Performance

Very Weak

Over the last 90 days Orior AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in August 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Basilea Pharmaceutica and Orior AG

The main advantage of trading using opposite Basilea Pharmaceutica and Orior AG positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Basilea Pharmaceutica position performs unexpectedly, Orior AG can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orior AG will offset losses from the drop in Orior AG's long position.

The idea behind Basilea Pharmaceutica AG and Orior AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.